{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:25:05Z","timestamp":1793913905386,"version":"4.8.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274008"],"award-info":[{"award-number":["82274008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073930"],"award-info":[{"award-number":["82073930"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejmech.2025.117666","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T11:06:18Z","timestamp":1745233578000},"page":"117666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Discovery of a CYP2E1 inhibitor and its therapeutic potential in severe acute pancreatitis"],"prefix":"10.1016","volume":"292","author":[{"given":"Jinhuan","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiakun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8533-344X","authenticated-orcid":false,"given":"Hailing","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2025.117666_bib1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.gastro.2021.09.043","article-title":"Global incidence of acute Pancreatitis is increasing over time: a systematic review and meta-analysis","volume":"162","author":"Iannuzzi","year":"2022","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.ejmech.2025.117666_bib2","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1053\/j.gastro.2019.01.268","article-title":"Early intra-acinar events in pathogenesis of pancreatitis","volume":"156","author":"Saluja","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117666_bib3","doi-asserted-by":"crossref","first-page":"Itc17","DOI":"10.7326\/AITC202102160","article-title":"Acute pancreatitis","volume":"174","author":"Gardner","year":"2021","journal-title":"Ann. Intern. Med."},{"issue":"10252","key":"10.1016\/j.ejmech.2025.117666_bib4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(20)31310-6","article-title":"Acute pancreatitis","volume":"396","author":"Boxhoorn","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117666_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cmi.2019.06.017","article-title":"Management of infected pancreatic necrosis in the intensive care unit: a narrative review","volume":"26","author":"Wolbrink","year":"2020","journal-title":"Clin. Microbiol. Infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117666_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.gastro.2019.09.040","article-title":"NLRP3 inflammasome regulates development of systemic inflammatory response and compensatory anti-inflammatory response syndromes in mice with acute pancreatitis","volume":"158","author":"Sendler","year":"2020","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117666_bib7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1053\/j.gastro.2017.10.018","article-title":"Cathepsin B-Mediated activation of trypsinogen in endocytosing macrophages increases severity of pancreatitis in mice","volume":"154","author":"Sendler","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117666_bib8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/gutjnl-2011-300771","article-title":"Tumour necrosis factor \u03b1 secretion induces protease activation and acinar cell necrosis in acute experimental pancreatitis in mice","volume":"62","author":"Sendler","year":"2013","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117666_bib9","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1053\/j.gastro.2017.08.071","article-title":"Autophagy, inflammation, and immune dysfunction in the pathogenesis of pancreatitis","volume":"153","author":"Gukovskaya","year":"2017","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117666_bib10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s40265-022-01766-4","article-title":"Acute pancreatitis: diagnosis and treatment","volume":"82","author":"Szatmary","year":"2022","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117666_bib11","first-page":"128","article-title":"Clinical practice guideline: management of acute pancreatitis","volume":"59","author":"Greenberg","year":"2016","journal-title":"Canadian journal of surgery. Journal canadien de chirurgie"},{"issue":"6","key":"10.1016\/j.ejmech.2025.117666_bib12","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1097\/MPA.0000000000002259","article-title":"Acute pancreatitis: current clinical approaches, molecular pathophysiology, and potential therapeutics","volume":"52","author":"Wiley","year":"2023","journal-title":"Pancreas"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117666_bib13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/03602532.2019.1632889","article-title":"A comprehensive review of cytochrome P450 2E1 for xenobiotic metabolism","volume":"51","author":"Chen","year":"2019","journal-title":"Drug Metab. Rev."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117666_bib14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/cells11020288","article-title":"Role of mitochondrial cytochrome P450 2E1 in healthy and diseased liver","volume":"11","author":"Massart","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117666_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/path.1711690412","article-title":"Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis","volume":"169","author":"Foster","year":"1993","journal-title":"J. Pathol."},{"issue":"47","key":"10.1016\/j.ejmech.2025.117666_bib16","doi-asserted-by":"crossref","first-page":"29643","DOI":"10.1074\/jbc.272.47.29643","article-title":"Oxidation kinetics of ethanol by human cytochrome P450 2E1. Rate-limiting product release accounts for effects of isotopic hydrogen substitution and cytochrome b5 on steady-state kinetics","volume":"272","author":"Bell","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2025.117666_bib17","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.3390\/ijms22158221","article-title":"CYP2E1 in alcoholic and non-alcoholic liver injury. Roles of ROS, reactive intermediates and lipid overload","volume":"22","author":"Harjum\u00e4ki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117666_bib18","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/jhep.2003.50342","article-title":"CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease","volume":"38","author":"Emery","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117666_bib19","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/hep.22222","article-title":"Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice","volume":"47","author":"Lu","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117666_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2125.2003.01731.x","article-title":"Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans","volume":"55","author":"Wang","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117666_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hepres.2003.08.001","article-title":"CYP2E1: from ASH to NASH","volume":"28","author":"Lieber","year":"2004","journal-title":"Hepatol. Res.: the official journal of the Japan Society of Hepatology"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117666_bib22","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.apsb.2022.02.004","article-title":"Crosstalk between CYP2E1 and PPAR\u03b1 substrates and agonists modulate adipose browning and obesity","volume":"12","author":"Zhang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117666_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115160","article-title":"Cytochrome P450 2E1 gene knockout or inhibition prevents obesity induced by high-fat diet via regulating energy expenditure","volume":"202","author":"Zhang","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117666_bib24","doi-asserted-by":"crossref","first-page":"E532","DOI":"10.1152\/ajpendo.00258.2011","article-title":"Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance","volume":"302","author":"Zong","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117666_bib25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1124\/jpet.117.245555","article-title":"Higher CYP2E1 activity correlates with hepatocarcinogenesis induced by diethylnitrosamine","volume":"365","author":"Gao","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117666_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1124\/jpet.116.233635","article-title":"Physiological content and intrinsic activities of 10 cytochrome P450 isoforms in human normal liver microsomes","volume":"358","author":"Zhang","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2025.117666_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115638","article-title":"The CYP2E1 inhibitor Q11 ameliorates LPS-induced sepsis in mice by suppressing oxidative stress and NLRP3 activation","volume":"214","author":"Gao","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117666_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116501","article-title":"Discovery of CYP2E1 as a novel target in rheumatoid arthritis and validation by a new specific CYP2E1 inhibitor","volume":"229","author":"Han","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"23","key":"10.1016\/j.ejmech.2025.117666_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301096","article-title":"Identification of cytochrome P450 2E1 as a novel target in glioma and development of its inhibitor as an anti-tumor agent","volume":"10","author":"Hu","year":"2023","journal-title":"Adv. Sci."},{"issue":"35","key":"10.1016\/j.ejmech.2025.117666_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202303975","article-title":"A novel cytochrome P450 2E1 inhibitor Q11 is effective on lung cancer via regulation of the inflammatory microenvironment","volume":"10","author":"Jia","year":"2023","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117666_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1124\/dmd.107.019265","article-title":"CYP2C19 inhibition: the impact of substrate probe selection on in vitro inhibition profiles","volume":"36","author":"Foti","year":"2008","journal-title":"Drug Metabol. Dispos.: the biological fate of chemicals"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117666_bib32","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1517\/17425255.4.8.1053","article-title":"Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective","volume":"4","author":"Miller","year":"2008","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117666_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.toxlet.2018.04.023","article-title":"In vitro evaluation of structural analogs of diallyl sulfide as novel CYP2E1 inhibitors for their protective effect against xenobiotic-induced toxicity and HIV replication","volume":"292","author":"Rahman","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117666_bib34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbadis.2018.08.017","article-title":"Inhibition of CYP2E1 attenuates myocardial dysfunction in a murine model of insulin resistance through NLRP3-mediated regulation of mitophagy","volume":"1865","author":"Ren","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117666_bib35","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1248\/bpb.28.1221","article-title":"Inhibition of human cytochrome P450 2E1 by halogenated anilines, phenols, and thiophenols","volume":"28","author":"Ohashi","year":"2005","journal-title":"Biol. Pharmaceut. Bull."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117666_bib36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/096032719701600505","article-title":"Low-dose diethyldithiocarbamate attenuates the hepatotoxicity of 1,3-dichloro-2-propanol and selectively inhibits CYP2E1 activity in the rat","volume":"16","author":"Stott","year":"1997","journal-title":"Hum. Exp. Toxicol."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117666_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235990","article-title":"Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis","volume":"15","author":"Diesinger","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.117666_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8854432","article-title":"A new CYP2E1 inhibitor, 12-Imidazolyl-1-dodecanol, represents a potential treatment for hepatocellular carcinoma","volume":"2021","author":"Diesinger","year":"2021","journal-title":"Canadian journal of gastroenterology & hepatology"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117666_bib39","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1124\/dmd.116.070193","article-title":"Selective Time- and NADPH-dependent inhibition of human CYP2E1 by clomethiazole","volume":"44","author":"Stresser","year":"2016","journal-title":"Drug Metabol. Dispos.: the biological fate of chemicals"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117666_bib40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00008571-199906000-00013","article-title":"Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans","volume":"9","author":"Lucas","year":"1999","journal-title":"Pharmacogenetics"},{"issue":"18","key":"10.1016\/j.ejmech.2025.117666_bib41","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/0024-3205(96)00132-4","article-title":"Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats","volume":"58","author":"Chen","year":"1996","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117666_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053038","article-title":"Concentration-dependent inhibitory effect of baicalin on the plasma protein binding and metabolism of chlorzoxazone, a CYP2E1 probe substrate, in rats in vitro and in vivo","volume":"8","author":"Gao","year":"2013","journal-title":"PLoS One"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425004313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425004313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:08:33Z","timestamp":1762265313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425004313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":42,"alternative-id":["S0223523425004313"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117666","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a CYP2E1 inhibitor and its therapeutic potential in severe acute pancreatitis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117666"}}